Pharmafile Logo

News and Press Releases

Evotec and Pfizer collaborate to advance drug discovery in France

Multi-year collaboration will initially focus on early discovery research for metabolic and infectious diseases 11 July 2024, Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:...

Category: Drug Discovery
Posted: July 11, 2024

Just – Evotec Biologics
info@evotec.com
Just – Evotec Biologics, Inc. 401 Terry Avenue North Seattle, WA 98109, US

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

Low doses of ETD001 demonstrate exceptionally long duration of action in sheep model of airway mucus clearance Report in Journal of Cystic Fibrosis discloses best-in-class profile of ETD001 ETD001 scheduled...

Category: Biotechnology, Clinical Trials, Drug Delivery, Drug Discovery, Pharmaceutical
Posted: June 12, 2024

Enterprise Therapeutics
info@enterprisetherapeutics.com
Sussex Innovation Centre, University of Sussex, Science Park Square, Falmer, Brighton, BN1 9SB, UK

Oxford Drug Design and CRUK Scotland Institute awarded MRC grant funding to advance novel cancer therapeutics discovery

Collaboration to use genetically engineered mouse models to validate a new approach to cancer therapy 4 June 2024 - United Kingdom - The CRUK (Cancer Research UK) Scotland Institute and Oxford...

Category: Drug Discovery
Posted: June 10, 2024

Oxford Drug Design
contactus@oxforddrugdesign.com
Oxford Drug Design Lt,d Oxford Centre for Innovation, New Road, Oxford, OX1 1BY, UK

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

Exploring advanced technologies to help bring novel therapies to patients faster Sartorius to leverage NVIDIA solutions used in live-cell imaging platforms in drug discovery, predictive design of manufacturing processes and...

Category: Biotechnology, Drug Discovery
Posted: May 16, 2024

Sartorius Group
info@sartorius.com
Sartorius Corporation, Otto-Brenner-Straße 20, 37079 Goettingen, Germany

Successful Conclusion of London Biotechnology Show, Leaves Attendees Highly Satisfied

10 May 2024 -- London, UK -- The curtain has closed on the debut London Biotechnology Show 2024, leaving attendees thoroughly impressed by the seamless delivery of promised content and...

Category: Biotechnology
Posted: May 10, 2024

London Biotechnology Show
info@londonbiotechshow.com

ELRIG UK Announces Profs Ijeoma Uchegbu and Marcus Schindler as Keynote Speakers at Drug Discovery 2024

Drug Discovery 2024: Connecting Minds, Transforming Science, Empowering Community will take place at ExCeL London from 2–3 October 2 May 2024 -- Cambridge, UK -- The European Laboratory Research &...

Category: Biotechnology, Drug Discovery
Posted: May 2, 2024

European Laboratory Research and Innovation Group (ELRIG)
info@elrig.org
ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK

How the Birmingham Drug Discovery Hub created an investment-ready ‘drug library’

18 April 2024 -- Birmingham, UK -- A novel approach to drug discovery is enabling University of Birmingham, UK, researchers to overcome the ‘valley of death’, where projects fail due...

Category: Drug Discovery
Posted: April 18, 2024

The University of Birmingham
Edgbaston Birmingham, B15 2TT

X‑Chem Adds Chief Technology Officer to Bolster Its Digital Drug Discovery Strategy 

2 April 2024 -- Massachusetts, US -- X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced the addition of Dr Erin Davis as chief technology officer....

Category: Drug Discovery
Posted: April 2, 2024

X-Chem
info@x-chemrx.com
100 Beaver Street Waltham, MA 02453

Semarion introduces SemaCyte Multiplexing Platform to enhance cell assay data quality and speed during drug discovery

Expansion to SemaCyte Microcarrier platform enables optical barcoding and pooling of adherent cells to augment drug discovery high-content imaging and other screening processes Access available through Semarion’s Early Adopter Programme....

Category: Drug Discovery
Posted: March 20, 2024

Semarion
info@semarion.com
Cavendish Laboratories JJ Thomson Ave Cambridge CB3 0HE UK

Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics

Agreement leverages Ubiquigent’s DUB-focused drug discovery platform to support the development of novel therapeutic candidates for multiple disease targets selected by Nanna Therapeutics 11 March 2024 -- Dundee, UK --...

Category: Drug Discovery
Posted: March 11, 2024

Ubiquigent
services@ubiquigent.com
University Incubator Dundee Technopole James Lindsay Place Dundee DD1 5JJ Scotland, UK

Aston University and University of Warwick team wins £1.8m for research to aid drug discovery and sustainable chemical production

The team will engineer cells to make membrane proteins efficiently The proteins will be used for drug discovery and screening, and as catalysts in sustainable chemical production The £1.8m Engineering...

Category: Drug Discovery
Posted: February 12, 2024

Aston University
Aston University Birmingham B4 7ET UK

ELRIG UK Establishes Engagement Strategy Work Group

Group aims to improve access to scientific programmes and grow ELRIG community 14 September 2023 -- Cambridge, UK -- The European Laboratory Research & Innovation Group (ELRIG) UK today announced...

Category: Drug Discovery
Posted: September 14, 2023

European Laboratory Research and Innovation Group (ELRIG)
info@elrig.org
ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK